Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | ifenprodil | 3689 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | ifenprodil | 3689 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | ifenprodil | 3689 | drug-path |
Axon guidance | R-HSA-422475 | map04360 | ifenprodil | 3689 | drug-path |
Tight junction | R-HSA-2134514 | map04530 | ifenprodil | 3689 | drug-path |
Asthma | R-HSA-444620 | map05310 | ifenprodil | 3689 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | ifenprodil | 3689 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | ifenprodil | 3689 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | ifenprodil | 3689 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | ifenprodil | 3689 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | ifenprodil | 3689 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | ifenprodil | 3689 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | scopoletin | 5280460 | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | scopoletin | 5280460 | drug-path |
Adherens junction | R-HSA-451386 | map04520 | scopoletin | 5280460 | drug-path |
Bladder cancer | R-HSA-9700206 | map05219 | scopoletin | 5280460 | drug-path |
Melanoma | Q9UHD0-PRO_0000015379 | map05218 | scopoletin | 5280460 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | scopoletin | 5280460 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | cefepime | 3035905 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | cefepime | 3035905 | drug-path |